Evidence map›Paper›PMID 34662466›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine.

N Cameli, M Silvestri, M Mariano, L Bennardo, S P Nisticò, A Cristaudo

Open access · greenAbstract readLetter
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022
    Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

N CameliDepartment of Dermatology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-6535-6935
M SilvestriDepartment of Health Sciences, Unit of Dermatology, Magna Graecia University, Catanzaro, Italy.ORCID https://orcid.org/0000-0002-1828-780X
M MarianoDepartment of Dermatology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-7964-3388
L BennardoDepartment of Health Sciences, Unit of Dermatology, Magna Graecia University, Catanzaro, Italy.ORCID https://orcid.org/0000-0002-0434-1027
S P NisticòDepartment of Health Sciences, Unit of Dermatology, Magna Graecia University, Catanzaro, Italy.ORCID https://orcid.org/0000-0002-3828-0883
A CristaudoDepartment of Dermatology, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-0737-983X
Magna Graecia University · ITSan Gallicano Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Erythema NodosumChAdOx1 nCoV-19HumansSARS-CoV-2ChAdOx1 nCoV-19

Identifiers

PMID34662466
PMCPMC9088690
OpenAlexW3207688551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.